1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Frenal, K.
Wecker, K.
Gurrola, G.B.
Possani, L.D.
Wolff, N.
Delepierre, M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proteins
PSFGEY
0867
0887-3585
56
367
375
10.1002/prot.20102
15211519
Exploring structural features of the interaction between the scorpion toxinCnErg1 and ERG K+ channels.
2004
10.2210/pdb1px9/pdb
pdb_00001px9
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
4746.415
ergtoxin
1
nat
polymer
no
no
DRDSCVDKSRCAKYGYYQECQDCCKNAGHNGGTCMFFKCKCA
DRDSCVDKSRCAKYGYYQECQDCCKNAGHNGGTCMFFKCKCA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Mexican scorpion
Centruroides
sample
6878
Centruroides noxius
venom
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2004-06-22
1
1
2008-04-29
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
RCSB
Y
RCSB
2003-07-03
REL
shigemi tube and nano-probe
structures with acceptable covalent geometry, structures with favorable non-bond energy, structures with the least restraint violations, structures with the lowest energy
10
1
2D NOESY
2D TOCSY
DQF-COSY
3
ambient
303
K
The structures are based on a total of 452 distance constraints (252 are intraresidual NOE-derivated distance constraints, 200 are interresidual NOE-derivated distance constraints including 49 long range), 13 3J and 10 hbonds
simulated annealing
1
fewest violations, lowest energy
0.55 mg of lyophilized natural ErgTx
0.160 mL, H2O/D2O 9:1, pH 3
Accelrys technologies
processing
Discover
insightII 2000
Accelrys technologies
data analysis
Discover
insightII 2000
Accelrys technologies
refinement
Discover
insightII 2000
500
Varian
INOVA
600
Varian
INOVA
ASP
1
n
1
ASP
1
A
ARG
2
n
2
ARG
2
A
ASP
3
n
3
ASP
3
A
SER
4
n
4
SER
4
A
CYS
5
n
5
CYS
5
A
VAL
6
n
6
VAL
6
A
ASP
7
n
7
ASP
7
A
LYS
8
n
8
LYS
8
A
SER
9
n
9
SER
9
A
ARG
10
n
10
ARG
10
A
CYS
11
n
11
CYS
11
A
ALA
12
n
12
ALA
12
A
LYS
13
n
13
LYS
13
A
TYR
14
n
14
TYR
14
A
GLY
15
n
15
GLY
15
A
TYR
16
n
16
TYR
16
A
TYR
17
n
17
TYR
17
A
GLN
18
n
18
GLN
18
A
GLU
19
n
19
GLU
19
A
CYS
20
n
20
CYS
20
A
GLN
21
n
21
GLN
21
A
ASP
22
n
22
ASP
22
A
CYS
23
n
23
CYS
23
A
CYS
24
n
24
CYS
24
A
LYS
25
n
25
LYS
25
A
ASN
26
n
26
ASN
26
A
ALA
27
n
27
ALA
27
A
GLY
28
n
28
GLY
28
A
HIS
29
n
29
HIS
29
A
ASN
30
n
30
ASN
30
A
GLY
31
n
31
GLY
31
A
GLY
32
n
32
GLY
32
A
THR
33
n
33
THR
33
A
CYS
34
n
34
CYS
34
A
MET
35
n
35
MET
35
A
PHE
36
n
36
PHE
36
A
PHE
37
n
37
PHE
37
A
LYS
38
n
38
LYS
38
A
CYS
39
n
39
CYS
39
A
LYS
40
n
40
LYS
40
A
CYS
41
n
41
CYS
41
A
ALA
42
n
42
ALA
42
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
GLY
15
A
N
GLY
15
A
O
CYS
34
A
O
CYS
34
A
N
THR
33
A
N
THR
33
A
O
LYS
40
A
O
LYS
40
1
12.46
1.10
114.20
126.66
A
A
A
CA
CB
SG
CYS
CYS
CYS
34
34
34
N
1
A
A
C
OXT
ALA
ALA
42
42
0.136
0.019
1.229
1.365
N
1
A
VAL
6
-131.15
-68.90
1
A
LYS
8
-84.33
48.64
1
A
TYR
17
-166.13
112.53
1
A
ASN
30
166.44
-64.55
1
A
MET
35
163.57
141.22
1
A
PHE
37
-166.03
36.04
Solution structure of the native CnErg1 Ergtoxin, a highly specific inhibitor of HERG channel
1
N
N
A
ARG
2
A
ARG
2
HELX_P
A
VAL
6
A
VAL
6
5
1
5
A
TYR
17
A
TYR
17
HELX_P
A
GLY
28
A
GLY
28
1
2
12
disulf
2.030
A
CYS
5
A
SG
CYS
5
1_555
A
CYS
23
A
SG
CYS
23
1_555
disulf
2.007
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
34
A
SG
CYS
34
1_555
disulf
2.016
A
CYS
20
A
SG
CYS
20
1_555
A
CYS
39
A
SG
CYS
39
1_555
disulf
2.022
A
CYS
24
A
SG
CYS
24
1_555
A
CYS
41
A
SG
CYS
41
1_555
TOXIN
alpha/beta molecular scaffold, TOXIN
A
MET
35
A
MET
35
1
A
PHE
36
A
PHE
36
-5.34
SEK1_CENNO
UNP
1
1
Q86QT3
DRDSCVDKSRCAKYGYYQECQDCCKNAGHNGGTCMFFKCKCA
1
42
1PX9
1
42
Q86QT3
A
1
1
42
3
anti-parallel
anti-parallel
A
TYR
14
A
TYR
14
A
GLY
15
A
GLY
15
A
GLY
32
A
GLY
32
A
MET
35
A
MET
35
A
CYS
39
A
CYS
39
A
CYS
41
A
CYS
41